Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

Conditions:   SARS-CoV-2 Infection;   Varicella;   Measles;   Mumps;   Rubella Interventions:   Biological: Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine;   Biological: Inactivated SARS-CoV-2 vaccine coadministered with MMR;   Biological: Inactivated SARS-CoV-2 vaccine administered alone Sponsors:   Shanghai Municipal Center for Disease Control and Prevention;   China National Biotec Group Company Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials